A comparative evaluation of the tissue responses associated with polymeric implants in the rat and mouse.

End product application is an important consideration when evaluating a material in an in vivo setting (Didisheim, Cardiovasc Pathol 1993;2:1S-2S). Small animal models allow high through-put evaluation of biocompatability. Previous preclinical evaluations have often used a rat subcutaneous model for the characterization of material-tissue interaction. Recent advances in genetic manipulation have provided mouse models with selective expression of a wide range of critical proteins. The rat model does not have many of the resources (i.e., knockouts, SCID, nude) that are present in mouse strains. The availability of these mice provides a resource to delineate the mechanisms regulating the healing associated with implants. However, before the mouse models can be used, they must be validated with respect to their ability to accurately assess tissue responses to materials. In this study the tissue responses after the implantation of expanded polytetrafluoroethylene (ePTFE) were compared between rat and mouse. Discs of ePTFE (30-microm internodal distance) were implanted in subcutaneous and epididymal fat tissue of rats (Sprague-Dawley) and mice (129-SVJ). After 5 weeks the samples were removed and evaluated for vascular density, inflammation, and fibrous encapsulation. No difference in the vessel density was observed within the peri-implant subcutaneous and adipose tissue or within the porous material. However, a significant difference was found in the number of activated macrophages and giant cells between these two species. Implants in the rat exhibited greater numbers of activated inflammatory cells in the peri-implant tissue. The data indicate that the mouse and rat provide a comparable model for evaluating angiogenesis and neovascularization associated with synthetic porous implants.

[1]  P. Didisheim,et al.  Current concepts of thrombosis and infection in artificial organs. , 1994, ASAIO journal.

[2]  Athel Cornish-Bowden,et al.  Silent genes given voice , 2022 .

[3]  J. Bellón,et al.  Similarity in behavior of polytetrafluoroethylene (ePTFE) prostheses implanted into different interfaces. , 1996, Journal of biomedical materials research.

[4]  J. Jansen,et al.  Tissue reaction to soft-tissue anchored percutaneous implants in rabbits. , 1994, Journal of biomedical materials research.

[5]  S. Berman,et al.  Inflammation and neovascularization associated with clinically used vascular prosthetic materials. , 1999, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[6]  S. Berman,et al.  Differential healing and neovascularization of ePTFE implants in subcutaneous versus adipose tissue. , 1997, Journal of biomedical materials research.

[7]  M. Reidy,et al.  Mechanisms of arterial graft healing. Rapid transmural capillary ingrowth provides a source of intimal endothelium and smooth muscle in porous PTFE prostheses. , 1986, The American journal of pathology.

[8]  G. Molema,et al.  The foreign body reaction to a biodegradable biomaterial differs between rats and mice. , 2000, Journal of biomedical materials research.

[9]  K. Kinzler,et al.  Genes expressed in human tumor endothelium. , 2000, Science.

[10]  R. C. Johnson,et al.  Neovascularization of synthetic membranes directed by membrane microarchitecture. , 1995, Journal of biomedical materials research.

[11]  W M Reichert,et al.  Engineering the tissue which encapsulates subcutaneous implants. I. Diffusion properties. , 1997, Journal of biomedical materials research.

[12]  W M Reichert,et al.  Engineering the tissue which encapsulates subcutaneous implants. II. Plasma-tissue exchange properties. , 1998, Journal of biomedical materials research.

[13]  M. Shults,et al.  A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration. , 2000, Diabetes care.

[14]  D. Cooley,et al.  Transmyocardial laser revascularization: histopathological findings. , 1998, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[15]  H. Lijnen,et al.  Accelerated neointima formation after vascular injury in mice with stromelysin-3 (MMP-11) gene inactivation. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[16]  D. Lockhart,et al.  Functional Genomics , 1999, Springer Netherlands.

[17]  J M Anderson,et al.  Inflammatory response to implants. , 1988, ASAIO transactions.

[18]  G I Murray,et al.  Proteomics: a new approach to the study of disease , 2000, The Journal of pathology.

[19]  Cord Sunderkötter,et al.  Macrophages and angiogenesis , 1994, Journal of leukocyte biology.

[20]  Timothy R Billiar,et al.  Impaired wound healing and angiogenesis in eNOS-deficient mice. , 1999, American journal of physiology. Heart and circulatory physiology.

[21]  M Gerritsen,et al.  Problems associated with subcutaneously implanted glucose sensors. , 2000, Diabetes care.

[22]  I. Vesely,et al.  Mineralization of glutaraldehyde-fixed porcine aortic valve cusps in the subcutaneous rat model: analysis of variations in implant site and cuspal quadrants. , 1999, Journal of biomedical materials research.